Related by context. Frequent words. (Click for all words.) 75 liposomal formulation 74 hypoxia inducible factor 74 dipeptidyl peptidase 4 74 selective inhibitor 74 partial agonist 74 humanized anti 73 orally bioavailable 72 Linaclotide 72 Panzem R 72 receptor antagonists 72 sphingosine 1 72 humanized monoclonal antibody 71 receptor agonist 71 Bortezomib 71 proteasome inhibitors 71 receptor antagonist 71 Bavituximab 71 Pivotal Phase 70 Naproxcinod 70 Ofatumumab 70 mTOR inhibitor 70 N methyl 70 Voreloxin 70 nucleoside analogue 70 Traficet EN 70 BMS # 70 potent inhibitor 70 investigational oral 70 6R BH4 70 MEK inhibitor 70 peroxisome proliferator activated 70 anticancer compound 70 CCX# 70 BAY #-# 69 Elesclomol 69 Initiates Phase 69 Carfilzomib 69 Perifosine 69 tyrosine kinase inhibitor 69 EGFr 69 Irinotecan 69 small molecule inhibitor 69 Mipomersen 69 Epratuzumab 69 luteinizing hormone releasing 69 LY# [002] 68 FGFR 68 angiogenesis inhibitor 68 selective estrogen receptor 68 Sym# 68 synthetic peptide 68 orally absorbed 68 Amrubicin 68 diabetic neuropathic pain 68 Drug Candidate 67 PS# [001] 67 antisense drug 67 selectively inhibit 67 Zolinza 67 Pioglitazone 67 LY# [003] 67 Nexavar ® 67 DB# [003] 67 Lenalidomide 67 neuroprotective properties 67 Aurora kinase 67 receptor agonists 67 non alcoholic steatohepatitis 67 fumarate 67 Pivotal Phase III 67 FLT3 67 Clinical Trial Results 67 epothilone 67 CYC# 66 GV# [001] 66 Monoclonal Antibody 66 CD# antibody [001] 66 pegylated 66 Inhibitor 66 Pegasys ® 66 Cethromycin 66 generation antisense 66 imatinib mesylate 66 SCH # 66 IGFBP 3 66 administered subcutaneously 66 selective inhibitors 66 anticancer agent 66 nucleoside 66 HGS ETR1 66 Hsp# inhibitors 66 injectable formulation 66 elotuzumab 66 investigational compounds 66 antibody fragment 66 thiazolidinedione 66 investigational compound 66 kinase inhibitor 66 Laquinimod 66 Erlotinib 66 TREANDA